IDBS Blog | 19th December 2014

It’s a Wrap: Looking Back at 2014

The holidays are upon us and, in among the tinsel and turkey, the end of the year is just around the corner. Before the clock strikes midnight to usher in 2015, let’s take a quick look back at just a few of the stand-out events of the past 12 months.

There have been a great number of scientific breakthroughs in 2014. From moving a step closer to a possible treatment for diabetes to testing blood plasma from young donors in Alzheimer’s patients, these and many other discoveries herald significant progress, which should be celebrated.

We’ve also seen the UK Government investing in life sciences and research and development (R&D), with the launch of MedCity back in April and support for a new science research centre in the North of England more recently. These moves are definitely positive steps, but whether these organizations can encourage open data sharing – which is vital to future R&D success – is yet to be seen.

This month also saw the Curiosity Rover find greater potential for life on Mars. After 28 months scouring the ‘red planet’, scientists now have significant insight into clues of ancient life. This is particularly exciting for us, having helped to test the power supplies for the Rover before its launch.

For IDBS too, it’s been a year of milestones. We’ve celebrated our 25th anniversary with the flagship Connect event in London, helping organizations discover products to transform R&D across the globe.

Our new Munich office opened as part of our continued commitment to the DACH region. The France and Southern European operations have also moved to new permanent premises in Paris.

With R&D remaining remarkably consistent across many scientific domains linked to different industries, we’ve also been helping a wider range of customers derive value from their data. 2014 saw us branch out into the energy sector, among others.

In short, it’s been a busy year for the industry and for us, but no doubt 2015 will bring new challenges and breakthroughs across the R&D spectrum.

Wishing you all happy holidays and an enjoyable New Year.

About IDBSContact us

More news

Webinar | November 30 | Managing the Journey from Process Development to Insight

In this session, you will learn how to build the right foundation to ensure confidence in the accuracy and availability of your data, understand how to get actionable insights from your bioprocess data to maximize cell culture productivity, and discover how out-of-the box workflows and integrations can curate a process data backbone that speeds time-to-insight with advanced data analytics and visualization tools.

Read more

IDBS Polar Insight

IDBS, a Danaher (NYSE:DHR) operating company, announced Polar Insight, bringing new advanced data analytics and visualization tools to the Polar BioPharma Lifecycle Management (BPLM) platform. Extracting valuable insights from process and quality data across the biopharmaceutical lifecycle is a time consuming and error prone process, requiring laborious manual work and multiple steps.

Read more

Skyland Analytics Acquisition

Global life sciences software company IDBS announces the acquisition of biopharmaceutical manufacturing data management and analytics software developer Skyland Analytics, in a move that will create the first BioPharma Lifecycle Management (BPLM) offering that supports therapies from early development through commercial manufacturing.

Read more

IDBS Acquires Skyland Analytics

Global life sciences software company IDBS announces the acquisition of biopharmaceutical manufacturing data management and analytics software developer Skyland Analytics, in a move that will create the first BioPharma Lifecycle Management (BPLM) offering that supports therapies from early development through commercial manufacturing. Skyland Analytics is best known for its Skyland PIMS™ software which seamlessly combines product, process, and patient data across the biopharma lifecycle and supply chain, providing insights that accelerate process understanding and ensure product quality.

Read more